Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control

Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control

Bibliographic Details
Main Authors:	Kyoung-Ho Pyo, S. M. Mazidur Rahman, Diana Boraschi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Oncology
Subjects:	AXL small molecule inhibitors antibodies tumor therapy therapy of infections
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1121120/full

Similar Items

Altered expression of AXL receptor tyrosine kinase in gastrointestinal cancers: a promising therapeutic target
by: Nataliya Pidkovka, et al.
Published: (2023-07-01)

SKI‐G‐801, an AXL kinase inhibitor, blocks metastasis through inducing anti‐tumor immune responses and potentiates anti‐PD‐1 therapy in mouse cancer models
by: Chun‐Bong Synn, et al.
Published: (2022-01-01)

The Development of AXL Inhibitors in Lung Cancer: Recent Progress and Challenges
by: Yun Beom Sang, et al.
Published: (2022-03-01)

Editorial: Exploring impacts of combined exposures to particles and chemicals on immune reactions across living organisms
by: Diana Boraschi, et al.
Published: (2023-03-01)

Small molecule inhibitors targeting the cancers
by: Gui‐Hong Liu, et al.
Published: (2022-12-01)

Editorial: Delivering nucleic acids to immune and non-immune cells
by: Kirill A. Afonin, et al.
Published: (2023-08-01)

Editorial: Immunological Effects of Nano-Imaging Materials
by: Yang Li, et al.
Published: (2022-03-01)

Cause or consequence? The role of IL-1 family cytokines and receptors in neuroinflammatory and neurodegenerative diseases
by: Diana Boraschi, et al.
Published: (2023-05-01)

An Evolutionary and Environmental Perspective of the Interaction of Nanomaterials with the Immune System
by: Diana Boraschi
Published: (2022-03-01)

Editorial: Targeted cancer therapies, from small molecules to antibodies, volume II
by: Chao-Yue Su, et al.
Published: (2023-06-01)

The SARS-CoV-2 Nucleoprotein Induces Innate Memory in Human Monocytes
by: Patricia Urbán, et al.
Published: (2022-07-01)

Environmental stress and nanoplastics’ effects on Ciona robusta: regulation of immune/stress-related genes and induction of innate memory in pharynx and gut
by: Rita Marino, et al.
Published: (2023-05-01)

Innate Immune Memory in Invertebrate Metazoans: A Critical Appraisal
by: Daniela Melillo, et al.
Published: (2018-08-01)

Editorial: Women in cytokines and soluble mediators in immunity
by: Diana Boraschi, et al.
Published: (2024-03-01)

Secondary Resistant Mutations to Small Molecule Inhibitors in Cancer Cells
by: Abdulaziz B. Hamid, et al.
Published: (2020-04-01)

From Antigen Delivery System to Adjuvanticy: The Board Application of Nanoparticles in Vaccinology
by: Diana Boraschi, et al.
Published: (2015-11-01)

Innate Immune Memory: Time for Adopting a Correct Terminology
by: Diana Boraschi, et al.
Published: (2018-04-01)

Induction of Innate Immune Memory by Engineered Nanoparticles: A Hypothesis That May Become True
by: Paola Italiani, et al.
Published: (2017-06-01)

Therapeutic Targeting of the Gas6/Axl Signaling Pathway in Cancer
by: Mai Tanaka, et al.
Published: (2021-09-01)

Assessing Immunological Memory in the Solitary Ascidian Ciona robusta
by: Daniela Melillo, et al.
Published: (2019-08-01)

Targeting AXL in NSCLC
by: Zaman A, et al.
Published: (2021-08-01)

The Receptor Tyrosine Kinase AXL in Cancer Progression
by: Erinn B. Rankin, et al.
Published: (2016-11-01)

Small Molecules—Prospective Novel HCMV Inhibitors
by: Elke Bogner, et al.
Published: (2021-03-01)

Methodological Approaches To Assess Innate Immunity and Innate Memory in Marine Invertebrates and Humans
by: Manon Auguste, et al.
Published: (2022-02-01)

Small-molecule inhibitors of kinases in breast cancer therapy: recent advances, opportunities, and challenges
by: Isha Bansal, et al.
Published: (2023-08-01)

Recent Advances in Small Molecule Inhibitors for the Treatment of Osteoarthritis
by: Jianjing Lin, et al.
Published: (2023-03-01)

Axl, Immune Checkpoint Molecules and HIF Inhibitors from the Culture Broth of <i>Lepista luscina</i>
by: Mihaya Kotajima, et al.
Published: (2022-12-01)

Anti-Axl antibody treatment reduces the severity of experimental autoimmune encephalomyelitis
by: Juwen C. DuBois, et al.
Published: (2020-10-01)

A Comprehensive Review of Clinical Cardiotoxicity Incidence of FDA-Approved Small-Molecule Kinase Inhibitors
by: Ying Jin, et al.
Published: (2020-06-01)

Small molecule inhibitors of mammalian glycosylation
by: Karim Almahayni, et al.
Published: (2022-12-01)

Small Molecule Inhibitors of Bcl-2 Family Proteins for Pancreatic Cancer Therapy
by: Ashiq Masood, et al.
Published: (2011-03-01)

Association between Microorganisms and Microplastics: How Does It Change the Host–Pathogen Interaction and Subsequent Immune Response?
by: Wenjie Yang, et al.
Published: (2023-02-01)

From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation
by: Paola eItaliani, et al.
Published: (2014-10-01)

Targeting of the AXL receptor tyrosine kinase by small molecule inhibitor leads to AXL cell surface accumulation by impairing the ubiquitin-dependent receptor degradation
by: Markus Lauter, et al.
Published: (2019-06-01)

Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges
by: Monica A. Kamal, et al.
Published: (2022-08-01)

Decreased epidermal AXL expression and increased infiltration of AXL‐expressing dendritic cells in psoriasis
by: Yukiko Ito, et al.
Published: (2023-12-01)

Review: Roy Dilley and Thomas G. Kirsch (eds.), Regimes of ignorance: anthropological perspectives on the production and reproduction of non-knowledge
by: Boraschi, D
Published: (2016)

Therapeutic strategies of glioblastoma (GBM): The current advances in the molecular targets and bioactive small molecule compounds
by: Hui Liu, et al.
Published: (2022-04-01)

Editorial: Recent advances in small molecule-based targeted therapy for breast cancer
by: Thet Thet Htar, et al.
Published: (2023-12-01)

Signaling Pathway and Small-Molecule Drug Discovery of FGFR: A Comprehensive Review
by: Jia Zheng, et al.
Published: (2022-04-01)